Last reviewed · How we verify
Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs
This study is a multi-centre, blinded, randomized controlled trial. LTCF residents ≥ 65 years who have received three doses of mRNA vaccine will be randomized to vaccination with a fourth dose of Pfizer-BioNtech mRNA- COVID-19 vaccine or to vaccination with a control (Prevnar-13 vaccine).
Details
| Lead sponsor | Mark Loeb |
|---|---|
| Phase | PHASE4 |
| Status | UNKNOWN |
| Enrolment | 414 |
| Start date | Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Dec 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- SARS-CoV2 Infection
- Coronavirus Infection
Interventions
- mRNA- COVID-19
- Prevnar13
Countries
Canada